ARCHIVES

Edward Harlow Returns to NCI As Special Assistant to Varmus

This article is from The Cancer Letter archive.

Vol. 37 No. 02 | January 14, 2011

Download PDF Visit The Full Archive

Related Articles

Afinitor Approved for Rare Disorder

November 5, 2010

FDA Pettiness Holds Up Trials with Promising Anticancer Drugs

November 14, 1975

Four DCCP Contracts Costing $9 Million Approved By Board for Recompetition

June 10, 1983

Novel Treatment Modalities Tested Against Bladder Cancer

May 27, 2005

Proposed Regulations for Center Grants In Federal Register

October 29, 1976

UICC Names Banker As Chief Executive

September 11, 2009